Medicine & Life Sciences
DNA Vaccines
100%
Vaccine Potency
57%
T-Lymphocytes
56%
Papillomavirus Vaccines
47%
Vaccination
47%
Neoplasms
45%
Human papillomavirus 16
34%
DNA
33%
Calreticulin
31%
Antigens
29%
CD8 Antigens
26%
Vaccines
25%
Immunotherapy
24%
Immunity
21%
Dendritic Cells
20%
Ovarian Neoplasms
19%
Uterine Cervical Neoplasms
18%
Papillomavirus Infections
15%
Therapeutic Uses
14%
Neoplasm Antigens
14%
Therapeutics
13%
Vaccinia
13%
Peptides
10%
HSP70 Heat-Shock Proteins
10%
Electroporation
10%
Tumor Microenvironment
9%
Proteins
9%
Genes
9%
mesothelin
8%
Cellular Immunity
8%
Antigen Presentation
8%
Sindbis Virus
8%
HLA-A2 Antigen
7%
Epitopes
7%
Coronavirus
7%
Lysosome-Associated Membrane Glycoproteins
7%
Interleukin-2
7%
Firearms
7%
Antigen-Presenting Cells
7%
Replicon
7%
Cancer Vaccines
6%
Vaccinia virus
6%
T-Lymphoid Precursor Cells
6%
Cytotoxic T-Lymphocytes
6%
Inbred C57BL Mouse
6%
Furocoumarins
6%
RA190
5%
Mycobacterium tuberculosis
5%
Cisplatin
5%
Histocompatibility Antigens Class II
5%
Agriculture & Biology
recombinant vaccines
22%
T-lymphocytes
12%
antigens
11%
neoplasms
11%
Human papillomavirus type 16
11%
calreticulin
10%
Papillomaviridae
10%
vaccines
8%
vaccination
7%
mice
6%
therapeutics
6%
immunotherapy
5%
dendritic cells
5%